NCT00202696 - Nalmefene Smoking Cessation Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions

Smoking Cessation

Interventions

DRUG

nalmefene

Nalmefene HCl film-coated tablets administered orally, twice daily, for total daily dosage of 40 or 80 mg, for 5 weeks (following a 2-week titration period).

OTHER

Placebo

Placebo tablets, administered orally, twice daily for 5 weeks (following a 2-week titration period).

Trial Locations (1)

55905

Mayo Clinic, Rochester